Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.51 |
| ▸ | CA2 | P00918 | 2/20 | 0.51 |
| ▸ | CA9 | Q16790 | 2/20 | 0.51 |
| ▸ | CA12 | O43570 | 1/20 | 0.51 |
| ▸ | STING1 | Q86WV6 | 2/20 | 0.49 |
| ▸ | HTR2A | P28223 | 7/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.49 |
| ▸ | HTR2C | P28335 | 1/20 | 0.49 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.48 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | DPP4 | P27487 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27176786 | 0.87 | CA1 (0.48) | CA1CA2CA9CA12STING1 | |
| SCHEMBL9115953 | 0.85 | HTR2A (0.54) | HTR2ATAAR1HTR2CMTNR1AMTNR1B | |
| SCHEMBL31456004 | 0.83 | HMGCR (0.49) | CA1CA2CA9CA12TAAR1 | |
| SCHEMBL14123786 | 0.80 | HSD17B10 (0.56) | CA1CA2CA9CA12HTR2A | |
| SCHEMBL27002113 | 0.80 | CYP3A4 (0.73) | HTR2ATAAR1HTR2CMTNR1AMTNR1B | |
| SCHEMBL15300735 | 0.80 | ALDH1A1 (0.47) | CA1CA2CA9CA12DPP4 | |
| SCHEMBL15270946 | 0.80 | KDM4E (0.50) | DPP4LMNAL3MBTL1ALDH1A1 | |
| SCHEMBL31026069 | 0.80 | ALDH1A1 (0.47) | CA1CA2CA9CA12DPP4 | |
| SCHEMBL31053274 | 0.80 | KDM4E (0.50) | DPP4LMNAL3MBTL1ALDH1A1 | |
| SCHEMBL31116543 | 0.79 | DPP4 (0.48) | CA1CA2CA9CA12MTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025059373-A1 | NOVEL PHENALKYLAMINES AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS | GILGAMESH PHARMACEUTICALS, INC. (US) | 2025-03-20 | — | — | WO | disclosed |